Petersen LC - Search Results

1

Regulation of the extrinsic pathway system in health and disease: the role of factor VIIa and tissue factor pathway inhibitor.

Petersen LC, Valentin S, Hedner U. Petersen LC, et al. Thromb Res. 1995 Jul 1;79(1):1-47. doi: 10.1016/0049-3848(95)00069-4. Thromb Res. 1995. PMID: 7495097 Review. No abstract available.

2

The effect of recombinant aprotinin on t-PA-induced bleeding in rats.

Erhardtsen E, Bregengaard C, Hedner U, Diness V, Halkjaer E, Petersen LC. Erhardtsen E, et al. Among authors: petersen lc. Blood Coagul Fibrinolysis. 1994 Oct;5(5):707-12. doi: 10.1097/00001721-199410000-00005. Blood Coagul Fibrinolysis. 1994. PMID: 7532446

3

Is tissue factor pathway inhibitor involved in the antithrombotic effect of heparins? Biochemical considerations.

Ostergaard P, Nordfang O, Petersen LC, Valentin S, Kristensen H. Ostergaard P, et al. Among authors: petersen lc. Haemostasis. 1993 Mar;23 Suppl 1:107-11. doi: 10.1159/000216919. Haemostasis. 1993. PMID: 8388348 Review.

4

Generation of Gla-domainless FVIIa by cathepsin G-mediated cleavage.

Nicolaisen EM, Petersen LC, Thim L, Jacobsen JK, Christensen M, Hedner U. Nicolaisen EM, et al. Among authors: petersen lc. FEBS Lett. 1992 Jul 20;306(2-3):157-60. doi: 10.1016/0014-5793(92)80989-t. FEBS Lett. 1992. PMID: 1633870 Free article.

5

Inhibitory effects of LDL-associated tissue factor pathway inhibitor.

Augustsson C, Hilden I, Petersen LC. Augustsson C, et al. Among authors: petersen lc. Thromb Res. 2014 Jul;134(1):132-7. doi: 10.1016/j.thromres.2014.03.043. Epub 2014 Apr 1. Thromb Res. 2014. PMID: 24787991

6

Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.

Petersen LC, Nørby PL, Branner S, Sørensen BB, Elm T, Stennicke HR, Persson E, Bjørn SE. Petersen LC, et al. Thromb Res. 2005;116(1):75-85. doi: 10.1016/j.thromres.2004.11.003. Epub 2004 Dec 7. Thromb Res. 2005. PMID: 15850611

7

Target-mediated clearance and bio-distribution of a monoclonal antibody against the Kunitz-type protease inhibitor 2 domain of Tissue Factor Pathway Inhibitor.

Hansen L, Petersen LC, Lauritzen B, Clausen JT, Grell SN, Agersø H, Sørensen BB, Hilden I, Almholt K. Hansen L, et al. Among authors: petersen lc. Thromb Res. 2014 Mar;133(3):464-71. doi: 10.1016/j.thromres.2013.12.015. Epub 2013 Dec 17. Thromb Res. 2014. PMID: 24393663

8

Effect of leukocyte proteinases on tissue factor pathway inhibitor.

Petersen LC, Bjørn SE, Nordfang O. Petersen LC, et al. Thromb Haemost. 1992 May 4;67(5):537-41. Thromb Haemost. 1992. PMID: 1519213

9

Microarray studies of factor VIIa-activated cancer cells.

Petersen LC. Petersen LC. Thromb Res. 2008;122 Suppl 1:S11-3. doi: 10.1016/S0049-3848(08)70011-2. Thromb Res. 2008. PMID: 18691491 Review.

10

Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.

Augustsson C, Svensson A, Kjaer B, Chao TY, Wenjuan X, Krogh BO, Breinholt J, Clausen JT, Hilden I, Petersen HH, Petersen LC. Augustsson C, et al. Among authors: petersen lc. J Thromb Haemost. 2018 May;16(5):893-904. doi: 10.1111/jth.14000. Epub 2018 Apr 6. J Thromb Haemost. 2018. PMID: 29532595 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page